IL6 and systemic sclerosis: Other profibrotic orchestrators implicated in SSc that have been investigated as potential therapeutic targets, even if not specifically for the inhibition of EndoMT, include oncostatin M, CTGF, IL-6, IL-1β and the chemokine c-c motif ligand 24 (CCL24) [43,117].